Johns Hopkins logo

Health Newsfeed

PROSTATE CANCER AND THREE DRUGS

THREE POPULAR DRUGS MAY BE ASSOCIATED WITH AN INCREASED RISK FOR PROSTATE CANCER, ELIZABETH TRACEY REPORTS

Benign prostatic hyperplasia or BPH is very common as men age, and so is baldness. Yet three drugs used to treat these conditions may result in an increased risk for aggressive prostate cancer, the FDA has warned. Patrick Walsh, a prostate cancer expert at Johns Hopkins, describes the problem.

WALSH: There are three agents, finasteride, which is marketed as Proscar for the treatment of an enlarged prostate, and Propecia, for baldness. And dutasteride, which is marketed as Avodart. These three drugs are useful. The issue, however, is whether or not they prevent prostate cancer, and the FDA has now come out loud and clear and said number one, they donít, and number two, you should not take them for that purpose because they may actually backfire on you and increase your risk of getting high grade prostate cancer.       :32

Walsh says these drugs are effective but should be used cautiously, after a man has been evaluated for the presence of prostate cancer. At Johns Hopkins, Iím Elizabeth Tracey.

Search Health NewsFeed

-----------------------------------------
Health NewsFeed Home | Hopkins Medicine Home